Skip to main content
. 2024 Dec 16;15:1447511. doi: 10.3389/fphar.2024.1447511

TABLE 3.

Dose calculations based on in vitro CLADVOS and calculated CLCRRT.

Treatment No extracorporeal support ADVOS CRRT
Settings BFR 100 mL/min CFR 160 mL/min DFR 800 mL/min BFR 200 mL/min CFR 320 mL/min DFR 800 mL/min BFR 200 mL/h DFR 2 L/h
CrCL (mL/min) >60 25 0 25 0 25 0 25 0
Dose calculations (mg/24 h) Standard licensed dose
Anidulafungin 100 100 100 180 180 180 180 100 100
Cefotaxime 6,000 3,080 2,100 4,070 3,090 4,810 3,830 3,560 2,590
Daptomycin 700 440 360 1,630 1,550 2000 1920 550 470
Fluconazole 800 380 240 2,780 2,640 4,770 4,630 1,660 1,520
Ganciclovir 800 260 80 540 360 820 640 450 270
Linezolid 1,200 930 840 1,440 1,350 1770 1,680 1,180 1,090
Meropenem 3,000 1,310 750 2,100 1,540 2,720 2,150 1770 1,200
Piperacillin 12,000 6,420 4,050 8,640 6,540 10,880 8,780 7,150 5,040

CrCL: creatinine clearance; BFR: blood flow rate; CFR: concentrate flow rate; DFR: dialysate flow rate; grey shaded rows depict drugs requiring higher dosages under ADVOS, compared to standard licensed drug regimens.